Gilead HIV Drug Health Risks Were Known Before First TDF-Based Antiretrovirals Hit The Market: Lawsuit
Earlier Gilead antiviral drugs using similar molecular formulations carried black box warnings due to the risks of kidney damage.
Tag Archives: Atripla
-
-
HIV Drug Settlement Reached to Resolve Class Action Over Truvada, Stribild, Other Antiretrovirals
Bristol-Myers Squibb has agreed to pay $10 million to resolve its part in the class action lawsuit over HIV drugs with allegedly inflated prices.
-
Gilead TDF Lawsuit Alleges Toxic Effects of HIV Drugs on Bones, Kidneys Was Known For Years
This and similar lawsuits claim Gilead sat on a safer formulation of its HIV drug for years in order to maximize its profits from the older, more toxic version.
-
Gilead Knew HIV Drug Compound TDF Was Toxic to Kidneys and Bones, Lawsuit Alleges
Lawsuit indicates Gilead sat on safer drug formulations until it completely cashed in on the older, more dangerous TDF-based HIV drugs.
-
Gilead Class Action Lawsuit Over TDF-Based HIV Drugs Allowed to Move Forward
-
Lawsuit Alleges Gilead HIV Drugs Placed Patients At Risk of Kidney and Liver Injuries To Maximize Profits
-
Lawsuit Filed Over Kidney and Bone Injuries From Truvada, Viread and Other Gilead HIV Drugs
-
Lawsuit Alleges Truvada, Other TDF-Based HIV Drugs Caused Kidney Disease, Bone Deterioration, Other Side Effects
-
Truvada Lawsuit Over Failure to Warn About HIV Drug Risks Allowed To Move Forward
-
Gilead Knew About Toxic Risks from Truvada, Atripla and Other HIV Drugs, Lawsuit Alleges
